Pathology for medical students: Difference between revisions
Jump to navigation
Jump to search
| (5 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
This article is an introduction to '''pathology for | This article is an introduction to '''pathology for medical students'''. | ||
==Compentencies== | ==Compentencies== | ||
| Line 16: | Line 16: | ||
**Knowing the difference between ''executer of the estate'' and ''power of attorney for health care decisions'' (not valid after death). | **Knowing the difference between ''executer of the estate'' and ''power of attorney for health care decisions'' (not valid after death). | ||
*Providing important clinical information. | *Providing important clinical information. | ||
**Clinical history - past medical history. | **[[Clinical history]] - past medical history. | ||
**Events leading-up to death. | **Events leading-up to death. | ||
**Provisional/suspected cause of death. | **Provisional/suspected cause of death. | ||
| Line 61: | Line 61: | ||
*[[Immunohistochemical stains]]. | *[[Immunohistochemical stains]]. | ||
**[[Cancers of unknown primary]]. | **[[Cancers of unknown primary]]. | ||
*Targeted therapies | *Targeted therapies/molecular testing: | ||
**Receptors in breast cancer. | **Receptors in breast cancer (ER, PR, HER2). | ||
**Lung cancer biomarkers ([[Lung_carcinoma_with_EGFR_mutation|EGFR]], [[Lung carcinoma with ALK rearrangement|ALK]], [[PD-L1]], [[ROS1-rearranged non-small cell lung carcinoma|ROS1]]). | |||
**BRAF testing in [[malignant melanoma]]. | |||
**[[Microsatellite instability in colorectal cancer|MSI testing]] in [[colorectal cancer]]. | |||
==See also== | ==See also== | ||